At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CLSN Celsion
Closed 09-20 16:00:00 EDT
1.96
+0.00
0.00%
High1.96
Low1.96
Vol0.00
Open1.96
D1 Closing1.96
Amplitude0.00%
Mkt Cap13.91M
Tradable Cap13.70M
Total Shares7.10M
T/O133.13K
T/O Rate0.00%
Tradable Shares6.99M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Introduction
Company Name.
Celsion
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Celsion Corporation, a clinical stage biotechnology company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and vaccines. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin, which is in Phase III clinical trial for the treatment of primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product, which is in Phase II clinical trials for the localized treatment of ovarian cancers. Celsion Corporation was founded in 1982 and is based in Lawrenceville, New Jersey.